In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.
Science on heart failure

Watch on-demand webinars on Late-Breaking Trials, and explore clinical cases, important HFA position papers, and more.


Access now

European Journal of Heart Failure

Advancing Knowledge in the Field of Heart Failure Management


The European Journal of Heart Failure (EJHF) is dedicated to the advancement of knowledge in the field of heart failure management.

The journal publishes reviews and editorials to improve the understanding, prevention, investigation and treatment of heart failure. Molecular and cellular biology, pathology, physiology, electrophysiology, pharmacology, as well as clinical, social and population sciences all form part of the discipline.

Fast Facts

  • Editor-in-chief: Marco Metra (IT)
  • Current volume: 23 (year 2021)
  • Issues per subscription: 12
  • Impact Factor 2019:  11.627


Editor in chief History


Name Start Date End Date
Professor John Cleland 01/01/1999 31/12/2004
Professor Karl Swedberg 01/01/2005 31/12/2009
Professor Dirk J. Van Veldhuisen 01/01/2010 31/12/2014
Professor Marco Metra 01/01/2018  
Updates on latest articles

Updates on latest articles


Receive the table of contents in your mailbox.

Track topics and authors important to you and receive articles in your mailbox.

For Authors

Before being published, all manuscripts go through double-blind peer review by experienced international experts.

Most recent articles from EJHF

08 Apr 2021
Why mechanical dyssynchrony remains relevant to cardiac resynchronization therapy: Reply
Author(s): Wilfried Mullens, Pieter Martens, Klaus Witte, Martin R. Cowie
07 Apr 2021
Cognitive function assessment for personalized HF disease management programmes
Author(s): João Pedro Ferreira
07 Apr 2021
Sodium–glucose co‐transporter 2 inhibitors for heart failure: clinical trial efficacy and clinical practice effectiveness
Author(s): Muhammad Shahzeb Khan, Gregg C. Fonarow, Stephen J. Greene
07 Apr 2021
Lower is not always the better: A better understanding of loop diuretics in HF
Author(s): Nicolas Girerd, G. Michael Felker